The WEIGHT Is Over- New Guidelines Help Optometrists Modify Plaquenil Risk

Plaquenil maculopathy is a rare, but visually debilitating complication of using hydroxychloroquine medication. This course details utilizing special testing including Visual Fields and OCT for diagnosis. The 2011 and 2016 American Academy of Ophthalmology management recommendations including treatment and follow-up will be discussed, including what height, weight, and dosage constitutes high risk. New information about risk modification will help the optometrist manage patients on Plaquenil.

Seminar Information
Seminar Date:
June 26, 2020
Seminar Objectives
  • 1. Educate about side effects of plaquenil maculopathy.
  • 2. Discuss testing for plaquenil maculopathy. OCT will be discussed in depth including using the 'flying saucer sign' to discover early toxic complication.
  • 3. Clear understanding of frequency of follow up and treatment strategies through case discussion.
The WEIGHT Is Over: New Guidelines Help Optometrists Modify Plaquenil Risk
Speaker Information
Anthony DeWilde
ProductAddPrice
On-Demand
AOA Price:$0.00
Individual topic purchase: Selected
American Optometric Association
AOA Approved: 1.00
Products
On-Demand
AOA Price:$0.00
Purchase Individual Topics
Selected